BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26153763)

  • 1. Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.
    Lamarthée B; Malard F; Gamonet C; Bossard C; Couturier M; Renauld JC; Mohty M; Saas P; Gaugler B
    Mucosal Immunol; 2016 Mar; 9(2):309-21. PubMed ID: 26153763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice.
    Song Q; Wang X; Wu X; Kang TH; Qin H; Zhao D; Jenq RR; van den Brink MRM; Riggs AD; Martin PJ; Chen YZ; Zeng D
    Nat Commun; 2021 Feb; 12(1):805. PubMed ID: 33547295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient-derived IL-22 alleviates murine acute graft-versus-host disease in association with reduced activation of antigen presenting cells.
    Pan B; Xia F; Wu Y; Zhang F; Lu Z; Fu R; Shang L; Li L; Sun Z; Zeng L; Xu K
    Cytokine; 2018 Nov; 111():33-40. PubMed ID: 30114627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
    Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
    Front Immunol; 2021; 12():647894. PubMed ID: 34262560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
    Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
    Front Immunol; 2018; 9():2724. PubMed ID: 30534126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system.
    Khorooshi R; Owens T
    J Immunol; 2010 Jul; 185(2):1258-64. PubMed ID: 20562259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease.
    Lu C; Ma H; Song L; Wang H; Wang L; Li S; Lagana SM; Sepulveda AR; Hoebe K; Pan SS; Yang YG; Lentzsch S; Mapara MY
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36445781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
    Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
    J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
    Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
    Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
    Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
    Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Cavet J; Dickinson AM; Norden J; Taylor PR; Jackson GH; Middleton PG
    Blood; 2001 Sep; 98(5):1594-600. PubMed ID: 11520812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I-IFNs control GVHD and GVL responses after transplantation.
    Robb RJ; Kreijveld E; Kuns RD; Wilson YA; Olver SD; Don AL; Raffelt NC; De Weerd NA; Lineburg KE; Varelias A; Markey KA; Koyama M; Clouston AD; Hertzog PJ; Macdonald KP; Hill GR
    Blood; 2011 Sep; 118(12):3399-409. PubMed ID: 21719602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.
    Walrath T; Malizia RA; Zhu X; Sharp SP; D'Souza SS; Lopez-Soler R; Parr B; Kartchner B; Lee EC; Stain SC; Iwakura Y; O'Connor W
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G479-G489. PubMed ID: 31790273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
    Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
    Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.
    Delisle JS; Gaboury L; Bélanger MP; Tassé E; Yagita H; Perreault C
    Blood; 2008 Sep; 112(5):2111-9. PubMed ID: 18552211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
    Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
    Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.